These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
237 related articles for article (PubMed ID: 21320309)
1. Viral-mediated oncolysis is the most critical factor in the late-phase of the tumor regression process upon vaccinia virus infection. Weibel S; Raab V; Yu YA; Worschech A; Wang E; Marincola FM; Szalay AA BMC Cancer; 2011 Feb; 11():68. PubMed ID: 21320309 [TBL] [Abstract][Full Text] [Related]
3. Replication efficiency of oncolytic vaccinia virus in cell cultures prognosticates the virulence and antitumor efficacy in mice. Chen NG; Yu YA; Zhang Q; Szalay AA J Transl Med; 2011 Sep; 9():164. PubMed ID: 21951588 [TBL] [Abstract][Full Text] [Related]
4. Preclinical evaluation of oncolytic vaccinia virus for therapy of canine soft tissue sarcoma. Gentschev I; Adelfinger M; Josupeit R; Rudolph S; Ehrig K; Donat U; Weibel S; Chen NG; Yu YA; Zhang Q; Heisig M; Thamm D; Stritzker J; Macneill A; Szalay AA PLoS One; 2012; 7(5):e37239. PubMed ID: 22615950 [TBL] [Abstract][Full Text] [Related]
5. Growth inhibition of different human colorectal cancer xenografts after a single intravenous injection of oncolytic vaccinia virus GLV-1h68. Ehrig K; Kilinc MO; Chen NG; Stritzker J; Buckel L; Zhang Q; Szalay AA J Transl Med; 2013 Mar; 11():79. PubMed ID: 23531320 [TBL] [Abstract][Full Text] [Related]
6. Colonization of xenograft tumors by oncolytic vaccinia virus (VACV) results in enhanced tumor killing due to the involvement of myeloid cells. Kilinc MO; Ehrig K; Pessian M; Minev BR; Szalay AA J Transl Med; 2016 Dec; 14(1):340. PubMed ID: 27993141 [TBL] [Abstract][Full Text] [Related]
7. An oncolytic vaccinia virus armed with anti-human-PD-1 antibody and anti-human-4-1BB antibody double genes for cancer-targeted therapy. Shi Z; Liu B; Huang C; Xie W; Cen Y; Chen L; Liang M Biochem Biophys Res Commun; 2021 Jun; 559():176-182. PubMed ID: 33945995 [TBL] [Abstract][Full Text] [Related]
8. Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus. Zhang Q; Yu YA; Wang E; Chen N; Danner RL; Munson PJ; Marincola FM; Szalay AA Cancer Res; 2007 Oct; 67(20):10038-46. PubMed ID: 17942938 [TBL] [Abstract][Full Text] [Related]
9. Features of the Antitumor Effect of Vaccinia Virus Lister Strain. Zonov E; Kochneva G; Yunusova A; Grazhdantseva A; Richter V; Ryabchikova E Viruses; 2016 Jan; 8(1):. PubMed ID: 26771631 [TBL] [Abstract][Full Text] [Related]
15. Efficient colonization and therapy of human hepatocellular carcinoma (HCC) using the oncolytic vaccinia virus strain GLV-1h68. Gentschev I; Müller M; Adelfinger M; Weibel S; Grummt F; Zimmermann M; Bitzer M; Heisig M; Zhang Q; Yu YA; Chen NG; Stritzker J; Lauer UM; Szalay AA PLoS One; 2011; 6(7):e22069. PubMed ID: 21779374 [TBL] [Abstract][Full Text] [Related]
16. Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy. Worschech A; Chen N; Yu YA; Zhang Q; Pos Z; Weibel S; Raab V; Sabatino M; Monaco A; Liu H; Monsurró V; Buller RM; Stroncek DF; Wang E; Szalay AA; Marincola FM BMC Genomics; 2009 Jul; 10():301. PubMed ID: 19583830 [TBL] [Abstract][Full Text] [Related]
17. Oncolytic vaccinia virus GLV-1h68 strain shows enhanced replication in human breast cancer stem-like cells in comparison to breast cancer cells. Wang H; Chen NG; Minev BR; Szalay AA J Transl Med; 2012 Aug; 10():167. PubMed ID: 22901246 [TBL] [Abstract][Full Text] [Related]
18. Combination of viral oncolysis and tumor-specific immunity to control established tumors. Chuang CM; Monie A; Wu A; Pai SI; Hung CF Clin Cancer Res; 2009 Jul; 15(14):4581-8. PubMed ID: 19584165 [TBL] [Abstract][Full Text] [Related]
19. Combination of fractionated irradiation with anti-VEGF expressing vaccinia virus therapy enhances tumor control by simultaneous radiosensitization of tumor associated endothelium. Buckel L; Advani SJ; Frentzen A; Zhang Q; Yu YA; Chen NG; Ehrig K; Stritzker J; Mundt AJ; Szalay AA Int J Cancer; 2013 Dec; 133(12):2989-99. PubMed ID: 23729266 [TBL] [Abstract][Full Text] [Related]
20. Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent. Gentschev I; Stritzker J; Hofmann E; Weibel S; Yu YA; Chen N; Zhang Q; Bullerdiek J; Nolte I; Szalay AA Cancer Gene Ther; 2009 Apr; 16(4):320-8. PubMed ID: 18949014 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]